All Articles

Litify is betting its next-gen AI can move beyond simple tasks to orchestrate firm-wide strategy. But can it bridge the gap between AI hype and real profit?

Following a $26M funding round, Epitel adds a proven commercial leader to its board, signaling a major push to dominate the remote neurology market.

eDiscovery Day 2026 is moving past hypotheticals. A live debate judged by a federal judge will determine AI's role, not just in law, but in our future.

Discover how SBB Research Group Foundation's model of sustained support for nonprofits is creating a new kind of return on investment: community resilience.

The era of the monolithic chip is ending. A new 'chiplet' model is rising, but how do these pieces connect? Arteris is building the digital nervous system.

Sumit Kapur’s recognition is more than an award; it signals a pivotal shift in quantum computing, where Boston-born strategy meets tangible application.

RegCell just raised $66M to advance its Nobel-winning Treg therapy. Can it move beyond broad immunosuppression and truly reset the body's immune system?

A new partnership aims to solve one of AI's biggest blind spots: who manages the machines? Descope's tech and IDMWORKS' reach may hold the key.

Cirrascale's Inference Platform offers a hardware-agnostic, private AI solution, aiming to tame runaway costs and vendor lock-in for enterprises.

In a major U.S.-Japan-Australia military exercise, startup Gallatin AI’s predictive software provided a critical logistical edge, signaling a new era for allied readiness.

Daniel Doimo, the architect of power giants, joins DG Matrix's advisory board, signaling a major shift in solving the energy crisis throttling AI's growth.

In the race for a 'longevity protein' therapy, a key safety milestone is met. This de-risks the path to the clinic, but what does it mean for the future?

Factor4's partnership with Shopley signals a major shift in Canadian retail tech. This alliance bets on unified commerce to win over merchants and shoppers.

ChatOn's new fact-checking tool aims to fight AI hallucinations and fake news. But in a world awash with AI-generated falsehoods, is it the solution or a paradox?

Pianist-turned-entrepreneur Doc Watkins is betting on a high-fidelity experience, building a physical network to rival our digital lives. Is this the future?

ERShares' XOVR ETF offers retail investors a tantalizing glimpse into pre-IPO giants like SpaceX, but a closer look reveals a complex web of high rewards and risks.

Schroders enters the U.S. autocallable ETF race with SALI, promising advisors a liquid, risk-managed solution. But is it the holy grail for income?

Axe Compute sells its Helomics cancer lab, completing its pivot to a pure-play AI infrastructure provider and betting its future on the GPU gold rush.

A two-person team at a civil construction firm now trains nearly 1,000 employees, thanks to AI. The results? A stellar safety record and a 40% retention boost.

At ECOC 2026, MACOM unveils the foundational tech for 3.2T optics and PCIe 7.0, signaling a critical move to solve the data bottlenecks that threaten to throttle AI.